Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentcell leading edge

PSD ATN1 CAPZB BCAR1 ITGA5 CIT ABLIM1 COBL TRPV4 PPP1R9B ADGRE5 PLD2

7.99e-0550013212GO:0031252
DomainTMEM183

TMEM183A TMEM183BP

4.59e-0521272IPR026509
DomainPDZ

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

5.06e-051411277PF00595
DomainNucleotide-bd_a/b_plait

RBMXL3 EIF4H CPSF6 RBM26 SRRT LARP4B DAZAP1 SYNJ1 RBM19

6.84e-052581279IPR012677
DomainPDZ

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

6.88e-051481277SM00228
Domain-

PSD DOK7 OBSCN CIT SHC3 RGS12 ARHGEF40 RASAL3 PLEKHG6 OSBPL5 PLD2

7.46e-05391127112.30.29.30
Domain-

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

7.49e-0515012772.30.42.10
DomainPDZ

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

7.81e-051511277PS50106
DomainPDZ

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

8.14e-051521277IPR001478
DomainPH

PSD DOK7 OBSCN CIT ARHGEF40 RASAL3 PLEKHG6 OSBPL5 PLD2

1.21e-042781279SM00233
DomainPH_DOMAIN

PSD DOK7 OBSCN CIT ARHGEF40 RASAL3 PLEKHG6 OSBPL5 PLD2

1.24e-042791279PS50003
DomainPH_domain

PSD DOK7 OBSCN CIT ARHGEF40 RASAL3 PLEKHG6 OSBPL5 PLD2

1.27e-042801279IPR001849
DomainPH_dom-like

PSD DOK7 OBSCN CIT SHC3 RGS12 ARHGEF40 RASAL3 PLEKHG6 OSBPL5 PLD2

1.59e-0442612711IPR011993
DomainRRM_dom

RBMXL3 EIF4H CPSF6 RBM26 LARP4B DAZAP1 SYNJ1 RBM19

1.63e-042271278IPR000504
DomainRRM

RBMXL3 EIF4H CPSF6 RBM26 LARP4B DAZAP1 SYNJ1 RBM19

1.79e-042301278PS50102
Domain-

RBMXL3 EIF4H CPSF6 RBM26 LARP4B DAZAP1 SYNJ1 RBM19

2.67e-0424412783.30.70.330
DomainRRM

RBMXL3 EIF4H CPSF6 RBM26 LARP4B DAZAP1 RBM19

7.14e-042171277SM00360
DomainVps4_C

KATNAL1 FIGNL1

1.25e-0381272IPR015415
Domain-

BAZ2A MBD2

1.25e-03812723.30.890.10
DomainVps4_C

KATNAL1 FIGNL1

1.25e-0381272PF09336
DomainPHD

JADE2 KDM5C BAZ2A KMT2A

1.71e-03751274PF00628
DomainMyb_DNA-binding

RCOR2 MTA1 JPT2

1.71e-03351273PF00249
DomainITAM_1

NFAM1 CD247

1.99e-03101272PS51055
DomainPhos_immunorcpt_sig_ITAM

NFAM1 CD247

1.99e-03101272IPR003110
DomainZnf_PHD-finger

JADE2 KDM5C BAZ2A KMT2A

2.07e-03791274IPR019787
DomainMYB_LIKE

RCOR2 MTA1 JPT2

2.18e-03381273PS50090
DomainMBD

BAZ2A MBD2

2.42e-03111272SM00391
DomainMBD

BAZ2A MBD2

2.42e-03111272PS50982
DomainMethyl_CpG_DNA-bd

BAZ2A MBD2

2.42e-03111272IPR001739
DomainMBD

BAZ2A MBD2

2.42e-03111272PF01429
DomainDNA-bd_dom

BAZ2A MBD2

2.42e-03111272IPR016177
DomainRRM_1

RBMXL3 EIF4H CPSF6 RBM26 DAZAP1 RBM19

3.01e-032081276PF00076
DomainPHD

JADE2 KDM5C BAZ2A KMT2A

3.19e-03891274SM00249
DomainELM2_dom

RCOR2 MTA1

3.41e-03131272IPR000949
DomainELM2

RCOR2 MTA1

3.41e-03131272PF01448
DomainELM2

RCOR2 MTA1

3.41e-03131272PS51156
DomainELM2

RCOR2 MTA1

3.41e-03131272SM01189
DomainZnf_PHD

JADE2 KDM5C BAZ2A KMT2A

3.45e-03911274IPR001965
DomainZF_PHD_2

JADE2 KDM5C BAZ2A KMT2A

4.03e-03951274PS50016
DomainZF_PHD_1

JADE2 KDM5C BAZ2A KMT2A

4.18e-03961274PS01359
DomainSANT

RCOR2 MTA1 JPT2

4.77e-03501273SM00717
DomainP4Hc

EGLN2 OGFOD1

5.17e-03161272SM00702
DomainAT_hook

BAZ2A KMT2A

5.17e-03161272PF02178
DomainPro_4_hyd_alph

EGLN2 OGFOD1

5.17e-03161272IPR006620
DomainSANT/Myb

RCOR2 MTA1 JPT2

5.32e-03521273IPR001005
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

LRRC24 POLR2A SIPA1L3 OBSCN ITGA5 BCL9 KLF4 CIT FAM83H URB1 ARHGEF40 SHANK2 SYNJ1 RBM19 IFRD2 PITX1 SCN8A OSBPL5 COBL HES6 AHNAK2

1.68e-0911051342135748872
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CBLL1 LZTS3 LRRC24 NPEPPS SIPA1L3 LMTK3 BCL9 GDI2 CIT RCOR2 ABLIM1 MAP7D1 SHANK2 SYNJ1 PRRC2C NCAN PPP1R9B PPP6R2 BEGAIN

5.95e-099631341928671696
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

CPSF6 POLD1 NPEPPS KDM5C POLR2A RBM26 OBSCN MON1A RGS12 FN3K MAP7D1 KMT2A COBL

7.29e-084971341336774506
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

CBLL1 CPSF6 POLD1 POLR2A SIPA1L3 RBM26 KLF4 CIT SRRT ABLIM1 LARP4B URB1 MAP7D1 MTA1 SHANK2 MICALL2 BAZ2A RBM19 IFRD2 KMT2A MBD2

2.98e-0714971342131527615
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

TMEM74B POLD1 BCAR1 PRX URB1 SHANK2 BAZ2A OSBPL5 SMARCD3 ADGRE5

6.48e-073291341017474147
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

KIF26B SIPA1L3 CAPZB BCAR1 RGS12 FAM83H ITPKB SRRT ABLIM1 MAP7D1 SYNJ1 PRRC2C KMT2A COBL AHNAK2

1.27e-068611341536931259
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

LZTS3 GDI2 CIT ABLIM1 SHANK2 SYNJ1 NCAN PPP1R9B BEGAIN

1.56e-06281134928706196
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

NECAB2 ATN1 LZTS3 RBM26 TGFB1I1 SRRT COBL PPP1R9B MBD2 MVP SF3B2 BEGAIN

1.92e-065601341221653829
Pubmed

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

ATN1 LZTS3 CPSF6 POLR2A BCL9 DAZAP1 JPT2 SF3B2

2.37e-06220134824550385
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

RBMXL3 CPSF6 NPEPPS SIPA1L3 TRPM2 RBM26 SHC3 SRRT LARP4B MAP7D1 ARHGEF40 DAZAP1 PRRC2C RBM19 EIF2B4 KMT2A MBD2 SF3B2

5.71e-0613711341836244648
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

ATN1 EIF4H CPSF6 POLD1 NPEPPS POLR2A SIPA1L3 CAPZB GDI2 CIT FAM83H SRRT ABLIM1 GSPT2 PPP6R2 MVP SF3B2

6.51e-0612471341727684187
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PSD ATN1 POLD1 KDM5C POLR2A DGKE RCOR2 FAM83H LARP4B MAP7D1 ARHGEF40 MTA1 RASAL3 BAZ2A SMARCD3 MBD2

6.66e-0611161341631753913
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ATN1 BCAR1 LMTK3 BCL9 PRX TGFB1I1 LARP4B MTA1 GSPT2 RASAL3

7.02e-064301341035044719
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

LZTS3 NPEPPS SIPA1L3 CAPZB GDI2 CIT ITPKB SRRT ABLIM1 MAP7D1 MGAT3 SHANK2 SYNJ1 PRRC2C NCAN KMT2A PPP1R9B PPP6R2

1.02e-0514311341837142655
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

TMEM183A JADE2 POLD1 NPEPPS CAPZB DGKE GCH1 ABLIM1 LARP4B URB1 MAP7D1 PRRC2C EIF2B4 KMT2A COBL CD74 FIGNL1 AHNAK2

1.11e-0514401341830833792
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

CPSF6 POLD1 POLR2A RBM26 MON1A TGFB1I1 SRRT ABLIM1 LARP4B SHANK2 EIF2B4 PITX1 PLD2 PPP6R2 BEGAIN

1.20e-0510381341526673895
Pubmed

CD3 and CD20 Immunohistochemical Staining Patterns of Bone Marrow-Infiltrating Malignant Lymphoma Cells.

CD247 MS4A1

1.47e-052134228442514
Pubmed

An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.

ITGA5 MGAT3

1.47e-052134219276077
Pubmed

FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.

MTA1 FMNL1

1.47e-052134230013189
Pubmed

Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup.

TMEM183A TMEM183BP

1.47e-052134216644869
Pubmed

Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.

KDM5C KMT2A

1.47e-052134232483278
Pubmed

Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.

MGAT3 SCN8A

1.47e-05213429061364
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

EIF4H CPSF6 POLR2A RBM26 GDI2 SRRT LARP4B URB1 GSPT2 DAZAP1 PRRC2C RBM19 SF3B2

1.54e-058071341322681889
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

EIF4H CPSF6 POLR2A RBM26 ABLIM1 SYNJ1 BAZ2A PRRC2C KMT2A PPP1R9B PPP6R2 JPT2 SF3B2 AHNAK2

1.60e-059341341433916271
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

JADE2 NPEPPS SIPA1L3 TRPM2 OBSCN TMEM183BP KATNAL1 BCAR1 ITPKB ABLIM1 SHANK2 DAZAP1 RAB5IF EIF2B4 OSBPL5 ZFHX2 COBL PPP1R9B

1.74e-0514891341828611215
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

EIF4H POLD1 NPEPPS POLR2A CAPZB PAPSS2 FAM83H SRRT URB1 MAP7D1 ARHGEF40 BAZ2A RBM19 EIF2B4 MVP SF3B2 AHNAK2

1.86e-0513531341729467282
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

EIF4H CPSF6 NPEPPS RBM26 CAPZB BCL9 GDI2 CIT MAP7D1 MTA1 DAZAP1 PRRC2C PITX1 KMT2A MBD2

2.43e-0511031341534189442
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

CBLL1 CPSF6 SIPA1L3 CAPZB CIT FAM83H SRRT ABLIM1 LARP4B MAP7D1 PRRC2C RBM19 EIF2B4 PPP1R9B MVP SF3B2

2.86e-0512571341636526897
Pubmed

Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.

JADE2 NFAM1 ARHGEF40

3.66e-0517134312693554
Pubmed

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.

EIF4H CPSF6 CAPZB GDI2 MVP JPT2 SF3B2

4.15e-05239134726641092
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

EGLN2 ATN1 EIF4H PGGHG OBSCN LMTK3 PLEKHG6 DAZAP1 RAB5IF SMARCD3 HES6 MBD2 JPT2 BEGAIN

4.22e-0510211341426760575
Pubmed

Self-regulated alternative splicing at the AHNAK locus.

PRX AHNAK2

4.41e-053134221940993
Pubmed

Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.

ITGA5 MGAT3

4.41e-053134214998999
Pubmed

ARS2/SRRT: at the nexus of RNA polymerase II transcription, transcript maturation and quality control.

POLR2A SRRT

4.41e-053134234060620
Pubmed

A HIC-5- and KLF4-dependent mechanism transactivates p21(Cip1) in response to anchorage loss.

KLF4 TGFB1I1

4.41e-053134223007394
Pubmed

Reciprocal Roles of Tom7 and OMA1 during Mitochondrial Import and Activation of PINK1.

TOMM7 PINK1

4.41e-053134230733118
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

ATN1 PAPSS2 SRRT MAP7D1 ARHGEF40 PRRC2C OGFOD1 KMT2A PPP6R2 FIGNL1 SF3B2

4.61e-056501341138777146
Pubmed

Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.

CPSF6 SRRT LARP4B PRRC2C

4.94e-0552134426265008
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

SRRT MTA1 BAZ2A KMT2A MBD2

5.09e-05103134532744500
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

GDI2 CIT ABLIM1 SHANK2 SYNJ1 NCAN BEGAIN

5.65e-05251134727507650
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

LMTK3 CIT ABLIM1 SHANK2 SYNJ1 PRRT3 PPP6R2 BEGAIN

6.34e-05347134817114649
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

KIF26B CPSF6 POLR2A RBM26 PRRC2C SF3B2 AHNAK2

6.40e-05256134733397691
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

ATN1 CPSF6 RBM26 BCL9 KLF4 KMT2A MBD2

8.52e-05268134733640491
Pubmed

The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress.

EGLN2 POLR2A

8.80e-054134218285459
Pubmed

TRIM39 deficiency inhibits tumor progression and autophagic flux in colorectal cancer via suppressing the activity of Rab7.

MON1A GDI2

8.80e-054134233846303
Pubmed

Polymorphisms of Nav1.6 sodium channel, Brain-derived Neurotrophic Factor, Catechol-O-methyltransferase and Guanosine Triphosphate Cyclohydrolase 1 genes in trigeminal neuralgia.

GCH1 SCN8A

8.80e-054134234418703
Pubmed

TRPV4 channels mediate the mechanoresponse in retinal microglia.

POLR2A TRPV4

8.80e-054134233624376
Pubmed

The topology of chromatin-binding domains in the NuRD deacetylase complex.

MTA1 MBD2

8.80e-054134233264408
Pubmed

Expression and genetic analysis of prtb, a gene that encodes a highly conserved proline-rich protein expressed in the brain.

ITGA5 SCN8A

8.80e-054134210373015
Pubmed

von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.

EGLN2 POLR2A

8.80e-054134220978146
Pubmed

The super elongation complex (SEC) family in transcriptional control.

POLR2A KMT2A

8.80e-054134222895430
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

SIPA1L3 SRRT ABLIM1 LARP4B COBL PPP1R9B SF3B2

9.77e-05274134734244482
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

POLR2A SRRT URB1 ARHGEF40 PRRC2C KMT2A

1.38e-04202134624639526
Pubmed

Antithetic effects of MBD2a on gene regulation.

POLR2A MBD2

1.46e-045134212665568
Pubmed

Paternal deletion of Meg1/Grb10 DMR causes maternalization of the Meg1/Grb10 cluster in mouse proximal Chromosome 11 leading to severe pre- and postnatal growth retardation.

COBL FIGNL1

1.46e-045134219174477
Pubmed

Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners.

DOK7 BCAR1

1.46e-045134228808245
Pubmed

The Shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation.

SHC3 CD247

1.46e-045134222242145
Pubmed

Involvement of TRPM2 and TRPM8 in temperature-dependent masking behavior.

TRPM2 TRPV4

1.46e-045134230842533
Pubmed

Genetic interaction mapping in mammalian cells using CRISPR interference.

MTA1 KMT2A SMARCD3 MBD2

1.50e-0469134428481362
Pubmed

Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.

SIPA1L3 CAPZB ABLIM1 PRRC2C PPP1R9B SF3B2 AHNAK2

1.54e-04295134726209609
Pubmed

Defining the membrane proteome of NK cells.

EIF4H CPSF6 POLD1 DGKE CIT LARP4B RASAL3 PRRC2C RBM19 OSBPL5 CD74 ADGRE5 MVP FMNL1

1.74e-0411681341419946888
Pubmed

High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy.

TOMM7 NPEPPS MICALL2 PINK1

1.77e-0472134424270810
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

WHRN EIF4H ABLIM1 MAP7D1 BAZ2A PRRC2C OGFOD1 COBL

1.90e-04407134812693553
Pubmed

The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.

ATN1 RBM26 PRRC2C

1.90e-0429134317577209
Pubmed

MLL associates specifically with a subset of transcriptionally active target genes.

POLR2A KMT2A

2.19e-046134216199523
Pubmed

ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.

EIF4H CPSF6 RBM26 CIT SRRT DAZAP1 PRRC2C

2.30e-04315134726777405
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NPEPPS POLR2A GDI2 LARP4B URB1 BAZ2A PRRC2C KMT2A MVP SF3B2

2.31e-046531341022586326
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

LZTS3 CAPZB DGKE FN3K MICU3 NCAN PPP1R9B BEGAIN

2.75e-04430134832581705
Pubmed

Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.

KDM5C KMT2A MBD2

2.80e-0433134326864203
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

LMTK3 CIT ABLIM1 SHANK2 PRRT3 BEGAIN

2.85e-04231134616452087
Pubmed

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

EIF4H POLR2A SIPA1L3 BCAR1 ABLIM1 CD247 MVP

2.88e-04327134715592455
Pubmed

Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion.

ITGA5 LMTK3

3.06e-047134228294115
Pubmed

Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand.

BCAR1 ITGA5

3.06e-047134216099422
Pubmed

Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation.

POLR2A KLF4

3.06e-047134226836306
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

KDM5C RBM26 KLF4 DCUN1D4 ZNF496 RCOR2 ABLIM1 ZNF716 BAZ2A HES6 SF3B2

3.07e-048081341120412781
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

POLD1 KDM5C POLR2A SRRT MTA1 SF3B2 AHNAK2

3.16e-04332134732786267
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

ATN1 CPSF6 BCL9 DAZAP1 FAM222B

3.17e-04152134538360978
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

CBLL1 CPSF6 POLR2A RBM26 SRRT MTA1 DAZAP1 BAZ2A PRRC2C RBM19 KMT2A SF3B2

3.34e-049541341236373674
Pubmed

A mutation in the Srrm4 gene causes alternative splicing defects and deafness in the Bronx waltzer mouse.

CIT SRRT SYNJ1 TRIM36

3.35e-0485134423055939
Pubmed

WW domains provide a platform for the assembly of multiprotein networks.

CPSF6 POLR2A DAZAP1 FMNL1 SF3B2

3.36e-04154134516055720
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

KDM5C RCOR2 MTA1 BAZ2A SMARCD3

3.68e-04157134530186101
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

CPSF6 POLR2A RBM26 SRRT BAZ2A KMT2A SF3B2

3.71e-04341134732971831
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

CPSF6 POLD1 POLR2A RBM26 CAPZB PAPSS2 SRRT MAP7D1 GSPT2 DAZAP1 PRRC2C RBM19 EIF2B4 SF3B2 AHNAK2

3.78e-0414151341528515276
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

CPSF6 POLR2A RBM26 SRRT

3.99e-0489134422446626
Pubmed

Genetic analysis of Down syndrome-associated heart defects in mice.

URB1 SYNJ1

4.06e-048134221442329
Pubmed

Hic-5 regulates an epithelial program mediated by PPARgamma.

KLF4 TGFB1I1

4.06e-048134215687259
Pubmed

The Vertebrate Genome Annotation browser 10 years on.

CBLL1 COL20A1 TTLL8 CD247 PITX1

4.36e-04163134524316575
Pubmed

New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.

TMEM183A POLD1 TMEM183BP LARP4B DAZAP1 PRRC2C EIF2B4 OSBPL5

4.42e-04462134831138677
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

POLD1 POLR2A CAPZB SRRT MAP7D1 MTA1 BAZ2A PITX1 SF3B2

4.49e-04583134929844126
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

EGLN2 JADE2 SIPA1L3 CIT FN3K ABLIM1 MTA1 DAZAP1 SYNJ1 CD74 MVP MGAT5B SF3B2 PINK1

4.55e-0412851341435914814
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

CPSF6 POLR2A SIPA1L3 CAPZB GDI2 SRRT MAP7D1 DAZAP1 PRRC2C SF3B2

4.65e-047141341028302793
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

LZTS3 CPSF6 CIT ABLIM1 LARP4B MICU3 GSPT2 SHANK2 SYNJ1 PRRC2C PPP1R9B PPP6R2 BEGAIN

4.75e-0411391341336417873
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

EIF4H CPSF6 POLD1 NPEPPS RBM26 CAPZB GDI2 MAP7D1 MTA1 PRRC2C EIF2B4 JPT2 SF3B2

5.16e-0411491341335446349
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

EIF4H LARP4B URB1 MAP7D1 MTA1 PRRC2C RBM19 PPP1R9B JPT2 AHNAK2

5.18e-047241341036232890
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

SIPA1L3 ITGA5 MAP7D1 MICU3 PRRC2C RBM19 FMNL1

5.21e-04361134726167880
Pubmed

Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.

KLF4 KMT2A

5.21e-049134226691508
Pubmed

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.

POLR2A KLF4

5.21e-049134222723415
Pubmed

Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.

EGLN2 MTA1

5.21e-049134216511565
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

POLR2A LMTK3 GDI2 SRRT SYNJ1 PRRC2C SCN8A FMNL1

5.31e-04475134831040226
Pubmed

TRIM65 regulates microRNA activity by ubiquitination of TNRC6.

CPSF6 POLR2A SRRT LARP4B EIF2B4 IFRD2 SF3B2

5.47e-04364134724778252
InteractionFBXO22 interactions

CPSF6 POLD1 NPEPPS KDM5C POLR2A RBM26 OBSCN MON1A BCAR1 KLF4 CIT RGS12 FN3K MAP7D1 KMT2A COBL

3.70e-0754012916int:FBXO22
InteractionZNF326 interactions

CPSF6 POLD1 POLR2A LMTK3 KLF4 CIT LARP4B GSPT2 PINK1

1.42e-052241299int:ZNF326
Cytoband7p12.1

COBL FIGNL1

3.75e-041013427p12.1
Cytoband16q23.3

NECAB2 SLC38A8

4.57e-0411134216q23.3
GeneFamilyPDZ domain containing

WHRN SIPA1L3 RGS12 PRX SHANK2 PPP1R9B AHNAK2

8.60e-061528771220
GeneFamilyRNA binding motif containing

RBMXL3 EIF4H CPSF6 RBM26 DAZAP1 RBM19

5.69e-04213876725
GeneFamilyMannosyl-glycoprotein N-acetylglucosaminyltransferases

MGAT3 MGAT5B

8.06e-049872435
GeneFamilyPHD finger proteins

JADE2 KDM5C BAZ2A KMT2A

9.33e-049087488
GeneFamilyZinc fingers CXXC-type|Methyl-CpG binding domain containing

BAZ2A MBD2

1.22e-03118721025
GeneFamilyPHD finger proteins|NuRD complex

MTA1 MBD2

1.46e-03128721305
GeneFamilyLIM domain containing

TGFB1I1 ABLIM1 MICALL2

2.88e-03598731218
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

WHRN DGKE KLF4 RGS12 PRX ITPKB FIGNL1

9.21e-071721347490745024730df6357f6c2b81d7a64e21557c0d5
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

JADE2 RBM26 ABLIM1 CD247 RASAL3 APOLD1 KMT2A

1.50e-061851347f1263899a2d41d182022dc4ca62cbae08a463c89
ToppCellControl-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

DOK7 CAPZB CD247 PIK3R6 MS4A1 CD74 LYL1

2.13e-061951347135234f068da3e8db7213b53c09ed6d1d0cdc351
ToppCellcontrol-Myeloid-CD16_Monocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GCH1 KLF4 PAPSS2 GDI2 CST3 CD74 MBD2

2.13e-061951347f398d08a23fdfa6202f73a7aeac3ff4c997fbdfd
ToppCell3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue

TMEM74B KLF4 CST3 COBL LYL1 AHNAK2 BEGAIN

2.35e-061981347920d2e6603a06c2e8dcb6be127202d222c662bca
ToppCell3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue

TMEM74B KLF4 CST3 COBL LYL1 AHNAK2 BEGAIN

2.35e-061981347807e3ed34739eca159dd0970f884b073e588c649
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.

TMEM74B PSD OBSCN ABLIM1 CST3 COBL PPP1R9B

2.52e-06200134761d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.

TMEM74B PSD OBSCN ABLIM1 CST3 COBL PPP1R9B

2.52e-0620013475c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM2 ARHGEF40 MGAT3 PIK3R6 PITX1 BEGAIN

9.08e-061601346fe9970c160159b35f6599ed13c89cfb49264d554
ToppCellCerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32

SIPA1L3 TRPM2 LMTK3 FAM83H SHANK2 FMNL1

1.16e-0516713469efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCellCerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32

SIPA1L3 TRPM2 LMTK3 FAM83H SHANK2 FMNL1

1.16e-051671346904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCellPND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PIDD1 SLC46A1 ARHGEF40 CST3 CD74 FIGNL1

1.37e-051721346eba1568d4307e91c94fc616549057cbed8df5840
ToppCellfacs-Aorta-Heart-24m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCAR1 KLF4 ITPKB ABLIM1 APOLD1 MBD2

1.66e-0517813468017aaecd6275d8173c516f6f3a68ea991f3c1b0
ToppCellfacs-Aorta-Heart-24m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCAR1 KLF4 ITPKB ABLIM1 APOLD1 MBD2

1.66e-05178134646333db0d205580189062bf9df839c97196ad161
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RASAL3 MS4A1 PVRIG CD74 LYL1 FMNL1

1.83e-0518113461110a0375189c034e6b02e6ebceb7084e4590114
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor

PGGHG SIPA1L3 PAPSS2 ABLIM1 SHANK2 COBL

2.07e-05185134632b4e68e551d435a732f253f6ad83408c759a642
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

JADE2 RBM26 ABLIM1 CD247 APOLD1 KMT2A

2.13e-051861346bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe
ToppCellfacs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RBM26 PAPSS2 MICU3 MS4A1 ZFHX2 CD74

2.33e-051891346010fdd70e9d0e21b856306a29ff877776a480319
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DGKE ITGA5 KLF4 PRX ITPKB PPP1R9B

2.40e-051901346106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue

ZMYND15 PAPSS2 CST3 COBL CD74 MBD2

2.47e-05191134644a797b39254cbfa5c2bad8155436adfd3019bb0
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZMYND15 GCH1 KLF4 PAPSS2 CST3 LYL1

2.55e-0519213467bcdbd97fa8c3bfccde426d44979601226913fc3
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TOMM7 LZTS3 ITPKB ABLIM1 CD247 PRRC2C

2.62e-0519313464e78ddc96d8e403a21c4a303b1f26512d2ac91e8
ToppCell3'_v3-Lung-Mast|Lung / Manually curated celltypes from each tissue

TGFB1I1 PIK3R6 COBL LYL1 AHNAK2 BEGAIN

2.70e-0519413465e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue

TGFB1I1 PIK3R6 COBL LYL1 AHNAK2 BEGAIN

2.70e-0519413467b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCellCOVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

PGGHG JADE2 OBSCN ITPKB ABLIM1 KMT2A

2.78e-0519513464bdedd924564a260841a9153604026b57487c83d
ToppCellControl-Myeloid-CD16_Mono|Control / Disease, Lineage and Cell Type

GCH1 KLF4 CST3 ADGRE5 LYL1 MBD2

2.78e-051951346a37e75be248ff28f6647e4e690629f82c1fb7370
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

KLF4 GDI2 PRX CST3 CD74 LYL1

2.78e-051951346cb27f6ca8b02438c353c9dff2f76d2656bb5b29a
ToppCellmild-Myeloid-CD16_Monocytes|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GCH1 KLF4 PAPSS2 GDI2 CST3 MBD2

2.78e-051951346e963d33b50d43e38cada738e41343b64e3d08b79
ToppCellCOVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 MBD2

2.86e-051961346af9e8f5ef9d03862f707e105857309b55595b1b9
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZMYND15 GCH1 KLF4 PAPSS2 CST3 LYL1

2.86e-05196134629246378ffb1010fe6858da756ae3d13df2306ba
ToppCellCOVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

2.94e-051971346c5837b9a5a39a0f607a4e217ade9fc87d82a5406
ToppCellSepsis-ICU-SEP-Lymphocyte-T/NK-NK_CD56bright|ICU-SEP / Disease, condition lineage and cell class

CPSF6 DOK7 KATNAL1 ABLIM1 MICU3 ZFP69B

2.94e-051971346c187e3fc2160b0165eb039cf09a6e621016068b7
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM2 CD247 RASAL3 MS4A1 ADGRE5 FMNL1

2.94e-05197134661ef3f417767c3f5296a26399da63e3e4f58faf8
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-0519813469b8679b3dd8f4220d71f607b7080cb88d6e71129
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-0519813468b6b602ebe59b6dca6a22f17385d3160ff3ac67e
ToppCellMild/Remission-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

TMEM74B DOK7 CAPZB CD247 MS4A1 CD74

3.03e-05198134644906dbf99ddd53335e2d32082ff7e77d91baaeb
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-051981346b9030390316baf456135f85f831394e1e11ecf3e
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KLF4 CST3 CD74 ADGRE5 LYL1 FMNL1

3.03e-051981346c00dbe61dc25602f19bd42a760646680002961ca
ToppCellmild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GCH1 KLF4 PAPSS2 GDI2 CST3 MBD2

3.03e-051981346ba97ff6e9d400b53ad013dce54afd7154a0f4fc9
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-051981346d36a3cda7e5f385d2391e9b0dfb027d3c4549320
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-0519813465436c3ed16e10e00c686f1ab0b0a68728a1a9985
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.03e-0519813464f67067d8142ca11b2d80195dac8d62a8d24d52c
ToppCellhealthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass

PGGHG JADE2 ABLIM1 CD247 MS4A1 KMT2A

3.11e-0519913462841e16d54acd344ba454f024e285c28abc37319
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

ZMYND15 GCH1 KLF4 PAPSS2 RGS12 CST3

3.20e-05200134658fbb7fc7159cbc417e6b457d60b7beba9b90da6
ToppCellhealthy_donor-Myeloid-Monocytic-CD14+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass

KLF4 NFAM1 ARHGEF40 CST3 CD74 SMARCD3

3.20e-052001346e4f4ac674f3e085f52c6affeb6aeadaec7fffa73
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NFAM1 MGAT3 MS4A1 CD74 PPP1R9B ZFP69B

3.20e-0520013464f7be296be0cd54cfc62cc93263fde26210c61f4
ToppCellP03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PAQR9 NFAM1 RASAL3 MS4A1 FMNL1

6.79e-0514113454a856521520ea73291f4730fe94c5de88c2b6f0c
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

JADE2 SNAI3 CD247 APOLD1 PNMA8A

8.01e-051461345159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e
ToppCellPND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZCWPW1 MS4A1 NCAN PRRT3 CD74

9.10e-051501345d6b977dd47aa017f6ba762f0c505cd896caa523f
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

POLD1 CIT TCEAL1 RASAL3 PLD2

9.10e-0515013456f7087a051a2f05c5611ff65a945c01736d5ec2b
ToppCellIIH-CD4-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster

GARIN5A ITPKB TGFB1I1 ZNF716 ZFP69B

9.99e-05153134528fb5d9f66f58741a5d43df004f80da3d910682e
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PGGHG SIPA1L3 MS4A1 CD74 FIGNL1

1.13e-0415713456730b775308f45a2f3946016bdbb7f8e5b5efe49
ToppCelldroplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABLIM1 RASAL3 MS4A1 PRRC2C FMNL1

1.20e-041591345997963d879e5819683793cddf5e1acff1b81a1b8
ToppCellPND10-Immune-Immune_Myeloid-DC-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZMYND15 NFAM1 CST3 CD74 SLC38A8

1.20e-0415913457bb76324d2026d4bd348126cb169c8411f0d7145
ToppCelldroplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABLIM1 RASAL3 MS4A1 PRRC2C FMNL1

1.20e-041591345e4eaa88772835d6b78e1a18a0cec52de51e80339
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WHRN TRPM2 NFAM1 FAM83H FIGNL1

1.23e-0416013455d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PAPSS2 RASAL3 DCLK3 SLC38A8 AHNAK2

1.23e-0416013455d22c86deead516444349d495998e04586be4396
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PAPSS2 RASAL3 DCLK3 SLC38A8 AHNAK2

1.23e-041601345ca212634cf1875238071d1800ecdf34979a553fb
ToppCelldroplet-Heart-nan-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAPSS2 APOLD1 CST3 CD74 PINK1

1.27e-041611345eb546d5065ac506405d240f9a1f55f2122d0c368
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZMYND15 CST3 CD74 TRIM36 BEGAIN

1.38e-04164134543045879505774ac0d9b7f760557955564f06d00
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD247 RASAL3 MS4A1 LYL1 FMNL1

1.38e-041641345f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1
ToppCellNS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LRRC24 TRPM2 CCDC168 LYL1 FMNL1

1.42e-0416513458b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86
ToppCellcontrol-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LRRC24 TRPM2 CCDC168 LYL1 FMNL1

1.42e-041651345243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCelldroplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM2 PIK3R6 MS4A1 CD74 LYL1

1.46e-041661345c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCelldroplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NFAM1 CST3 CD74 LYL1 FMNL1

1.46e-0416613451a3a15d1fc76bb91d832cdc6e3da0a6140b94b75
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRPM2 NFAM1 PIK3R6 CD74 FMNL1

1.51e-0416713451bd0aa7a3c8649f342bb856cf861c4c5984ad889
ToppCellPND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZCWPW1 FN3K CST3 CD74 TRPV4

1.55e-041681345cc0dd43d5cda01e643d8e8d74ec7617d61890760
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

CBLL1 KIF26B ZNF496 OSBPL5 SMARCD3

1.55e-041681345c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCellDendritic_Cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

SNAI3 CST3 CD74 LYL1 FMNL1

1.55e-04168134533618e5dbcee31f30afacacc9f6046782c100fb3
ToppCelldroplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GCH1 FN3K CD247 NCAN CD74

1.59e-0416913458e7a30eb546fc6fa184ebb76f54b74b278005a84
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 OBSCN KLF4 TCEAL1 CACNG4

1.59e-0416913457be742160e3e7e6c8f86b037be4e425f4d4cf663
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 OBSCN KLF4 TCEAL1 CACNG4

1.59e-0416913454ccf5cfa4fe72d3af056d658460a9ccaa07b01be
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RASAL3 MS4A1 CD74 LYL1 FMNL1

1.64e-041701345e319ab46842d028898c09d6d8f056f896edb1558
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

LMTK3 CIT SHC3 LARP4B SHANK2

1.64e-041701345a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCelldroplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NFAM1 CST3 CD74 LYL1 FMNL1

1.64e-0417013454d28dc9eb572f43809619f923978cd7494853d43
ToppCelltumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass

WHRN SNAI3 IGSF22 PLEKHG6 SMARCD3

1.68e-041711345dcb6c41980008d0b9eeb54999faff77311554976
ToppCelldroplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NFAM1 CST3 CD74 LYL1 FMNL1

1.68e-041711345ed5886d6aa87b2d73469d39dc217227bd4d4c918
ToppCelldroplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLF4 NFAM1 CST3 LYL1 FMNL1

1.73e-04172134551bea97564a33f0060c546c9be4bf8bf8f1660f6
ToppCelldroplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLF4 NFAM1 CST3 LYL1 FMNL1

1.73e-041721345be4dd4ba8d7a651677c797c25fd75f14e627415a
ToppCellfacs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

POLR2A KLF4 MS4A1 CD74 LYL1

1.73e-0417213450c6332a806ac75fffae6080f61965555c7f687f4
ToppCelldroplet-Liver-Npc-18m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNAI3 ABLIM1 CD247 RASAL3 FMNL1

1.73e-041721345f45489e80c59b824846ffda675de0d118a8b850c
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOK7 PIDD1 MON1A APOLD1 SCN8A

1.77e-041731345506efcaa5afd6ed5e565c4c4def6a4505fea97c5
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WHRN LRRC24 HES6 CACNG4 MGAT5B

1.77e-0417313452b448acd5e584f24567204c31b8d74715e92f32a
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMTK3 KLF4 ABLIM1 MS4A1 CD74

1.77e-041731345e944ea3a0a368f856efacbda4600605cf751dd9c
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMTK3 KLF4 ABLIM1 MS4A1 CD74

1.77e-04173134585fa5918e9c1f6bb4757e3350cfc71ee75c55640
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WHRN LRRC24 HES6 CACNG4 MGAT5B

1.77e-0417313455086edc29c5a6137ca09877929a1317f9739c801
ToppCelldroplet-Lung-nan-21m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFAM1 CST3 CD74 LYL1 FMNL1

1.82e-041741345763ca53339d9e236da8463f2a9d1bd39d4385d75
ToppCellfacs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WHRN POLD1 ABLIM1 MS4A1 CD74

1.82e-0417413458bdf5a97faf1cf0426d1a8851f8a3e27578f7598
ToppCellfacs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WHRN POLD1 ABLIM1 MS4A1 CD74

1.82e-041741345fbf998dd33ac27dad7639ea85fca393ba2835307
ToppCellControl-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations)

PGGHG PAPSS2 ABLIM1 SHANK2 COBL

1.82e-041741345548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM2 NFAM1 RASAL3 ADGRE5 FMNL1

1.87e-041751345e991ffa4d1d278a011592b9915cd35fe76db20cc
ToppCellfacs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TGFB1I1 ZFHX2 TRPV4 CACNG4 TRIM36

1.87e-041751345f1166b567bca80dac3abe90c3dc544c831006640
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

JADE2 RBM26 CD247 RASAL3 FIGNL1

1.92e-0417613456b1cf1e98b4509e87f9eea827fa7090ce1e504f1
ToppCelldroplet-Marrow-nan-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GCH1 FN3K MS4A1 IFRD2 CD74

1.92e-041761345f92063b72ebfeb9b192281dc63d6bf2759c78554
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SNAI3 CD247 RASAL3 PVRIG FMNL1

1.97e-0417713457d73643beb007032e757f2611121c4f3027aecf5
ToppCelldroplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 POLD1 PIDD1 MS4A1 CD74

1.97e-041771345a58c93be9767e3fe8fbb6b0db1210d3a33aac662
ToppCelldroplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 POLD1 PIDD1 MS4A1 CD74

1.97e-0417713453ed383e5c0b15d9d5e75b98cf6d10609f48fc422
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DOK7 FAM83H MGAT3 PITX1 TRPV4

2.03e-041781345b89c4d015b44bf538aa39969ef8778877c8023f1
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NECAB2 PSD TRPM2 PRRT3 BEGAIN

2.03e-041781345a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd
ToppCelldroplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABLIM1 CD247 RASAL3 PRRC2C KMT2A

2.03e-0417813458aef208b6351143562c87715bb11628880abce94
DrugZardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A

WHRN ATN1 BCL9 RGS12 SHANK2 RBM19 SMARCD3 ADGRE5 TRIM36

2.02e-0619413297347_UP
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A

LZTS3 URB1 MTA1 MICALL2 BAZ2A ZFHX2 SMARCD3 ADGRE5 AHNAK2

2.20e-0619613295568_DN
DrugMafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A

ATN1 LZTS3 CPSF6 DGKE BCL9 DCUN1D4 LARP4B PITX1 TRIM36

2.20e-0619613295499_DN
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A

KDM5C PIDD1 SHANK2 BAZ2A RBM19 FAM222B PITX1 ZFHX2 PLD2

2.30e-0619713295746_DN
DrugNiacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A

WHRN ATN1 LZTS3 SHANK2 ZFHX2 KMT2A SMARCD3 PPP6R2 AHNAK2

2.50e-0619913293381_DN
DrugSaquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A

NECAB2 ATN1 PGGHG MGAT3 GSPT2 BAZ2A PNMA8A CD74 PPP6R2

2.60e-0620013293549_UP
DrugMethotrexate [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

WHRN ATN1 CAPZB PIDD1 DGKE PNMA8A SMARCD3 CACNG4

1.38e-0518713285419_UP
DrugNadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A

CBLL1 ATN1 PIDD1 SHANK2 SYNJ1 CST3 TRIM36 AHNAK2

1.80e-0519413284139_UP
DrugNialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A

WHRN ATN1 LZTS3 PIDD1 RGS12 TGFB1I1 PLEKHG6 SMARCD3

1.87e-0519513283871_DN
DrugAzacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A

LZTS3 PGGHG KDM5C RGS12 ABLIM1 RBM19 PITX1 LYL1

1.87e-0519513281520_DN
Drugestradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A

LZTS3 PAPSS2 SYNJ1 BAZ2A ZFHX2 KMT2A SMARCD3 MVP

1.87e-0519513282668_UP
DrugMetoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A

ATN1 JADE2 DGKE KLF4 ITPKB SYNJ1 RBM19 ZFHX2

1.94e-0519613282315_DN
DrugDNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A

ATN1 LZTS3 ITGA5 BAZ2A RBM19 PITX1 ZFP69B BEGAIN

1.94e-0519613287513_DN
DrugCephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A

ZCWPW1 LZTS3 KDM5C KLF4 MTA1 MICALL2 ADGRE5 PPP6R2

1.94e-0519613283471_DN
DrugEpirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A

ATN1 PIDD1 CD247 MTA1 MS4A1 RBM19 ADGRE5 LYL1

1.94e-0519613281681_UP
DrugPseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; HL60; HG-U133A

ATN1 LZTS3 PIDD1 RGS12 ARHGEF40 EIF2B4 CACNG4 PPP6R2

2.01e-0519713281774_UP
DrugGuanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A

WHRN ATN1 KDM5C SRRT URB1 MS4A1 BAZ2A TRPV4

2.01e-0519713285703_UP
DrugNimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A

LZTS3 BCL9 ITPKB SRRT MICALL2 APOLD1 PITX1 SMARCD3

2.01e-0519713282275_DN
DrugDeltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A

ATN1 SIPA1L3 PIDD1 RGS12 MS4A1 KMT2A TRIM36 MBD2

2.08e-0519813286026_UP
DrugCP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A

LZTS3 RGS12 URB1 MGAT3 NCAN TRIM36 LYL1 AHNAK2

2.08e-0519813284383_UP
DrugFlumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A

KIF26B RGS12 PRX URB1 CD247 MGAT3 PLEKHG6 PNMA8A

2.08e-0519813285104_UP
DrugTyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A

LZTS3 KDM5C ARHGEF40 MS4A1 ZFHX2 TRIM36 MBD2 BEGAIN

2.08e-0519813285672_UP
DrugBetahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A

ATN1 SIPA1L3 DGKE GCH1 ABLIM1 GSPT2 MVP BEGAIN

2.08e-0519813282472_UP
DrugCiprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A

KDM5C URB1 MTA1 APOLD1 BAZ2A RBM19 PITX1 ZFHX2

2.16e-0519913285740_DN
DrugTerazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

LZTS3 ITGA5 TGFB1I1 SRRT BAZ2A KMT2A SMARCD3 LYL1

2.16e-0519913286092_DN
DrugAltretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A

WHRN LZTS3 RGS12 PRX SRRT URB1 MGAT3 TRPV4

2.16e-0519913285688_UP
DrugBrompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A

WHRN SIPA1L3 PIDD1 SRRT MTA1 PLEKHG6 PITX1 PPP6R2

2.16e-0519913284013_DN
DrugNorethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A

LZTS3 SIPA1L3 BCL9 RGS12 LARP4B PITX1 TRIM36 PPP6R2

2.24e-0520013285474_DN
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A

WHRN ATN1 LZTS3 DGKE RGS12 TGFB1I1 ZFHX2 SMARCD3

2.24e-0520013283907_DN
DrugPancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A

ATN1 RGS12 MTA1 PLEKHG6 MS4A1 NCAN CD74 CACNG4

2.24e-0520013287329_UP
DrugPhentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A

ATN1 SIPA1L3 ITGA5 RGS12 ITPKB MTA1 RBM19 PITX1

2.24e-0520013282323_DN
DrugMetyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A

PRX URB1 APOLD1 RBM19 CD74 LYL1 MVP

1.28e-0419113275667_UP
DrugPyrantel tartrate [33401-94-4]; Down 200; 11.2uM; HL60; HG-U133A

POLD1 MAP7D1 RBM19 CST3 ADGRE5 LYL1 SF3B2

1.32e-0419213271413_DN
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA

KDM5C PIDD1 ITGA5 RGS12 ITPKB SRRT ABLIM1

1.32e-041921327849_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A

PIDD1 URB1 MICALL2 RBM19 PITX1 SCN8A SMARCD3

1.36e-0419313275074_DN
DrugRicinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A

KDM5C SIPA1L3 RBM26 MGAT3 MICALL2 APOLD1 RBM19

1.36e-0419313272505_DN
DrugThiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A

LZTS3 KDM5C SIPA1L3 DGKE ITPKB APOLD1 LYL1

1.36e-0419313272894_DN
DrugEthynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A

TMEM74B PGGHG PRX SYNJ1 BAZ2A KMT2A COBL

1.36e-0419313276678_UP
Drug0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A

ATN1 KDM5C POLR2A SRRT MTA1 CACNG4 PLD2

1.41e-0419413274331_DN
DrugMetoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A

ATN1 LZTS3 SIPA1L3 SRRT RBM19 CACNG4 PPP6R2

1.41e-0419413273625_DN
Drugradicicol; Down 200; 0.1uM; PC3; HT_HG-U133A

TMEM74B ATN1 KLF4 ARHGEF40 COBL CACNG4 BEGAIN

1.41e-0419413275952_DN
DrugHaloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

WHRN TGFB1I1 SRRT CD247 MTA1 SHANK2 ZFHX2

1.45e-0419513271539_UP
DrugCarbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A

TGFB1I1 PLEKHG6 APOLD1 PITX1 CACNG4 TRIM36 PPP6R2

1.45e-0419513275399_DN
DrugGentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A

WHRN ZCWPW1 KDM5C PIDD1 BCL9 RGS12 MVP

1.45e-0419513272245_DN
DrugProcyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A

LZTS3 CPSF6 RGS12 TGFB1I1 LARP4B ZFHX2 CACNG4

1.45e-0419513273330_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A

ATN1 LZTS3 JADE2 DGKE RGS12 SYNJ1 TRIM36

1.45e-0419513273942_DN
Drug5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA

ATN1 LZTS3 RGS12 ZFHX2 CD74 ADGRE5 PLD2

1.45e-041951327838_UP
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A

ZCWPW1 BCL9 RBM19 PITX1 PLD2 PPP6R2 PINK1

1.45e-0419513271665_DN
DrugTomatidine [77-59-8]; Down 200; 9.6uM; HL60; HG-U133A

JADE2 NPEPPS PIDD1 DCUN1D4 LARP4B PRRC2C FAM222B

1.45e-0419513271754_DN
DrugPropylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A

PAPSS2 SRRT SYNJ1 APOLD1 PITX1 TRIM36 AHNAK2

1.45e-0419513274157_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

ATN1 SYNJ1 APOLD1 BAZ2A ZFHX2 ADGRE5 PPP6R2

1.50e-0419613275604_DN
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A

WHRN SHANK2 SCN8A ZFHX2 KMT2A SMARCD3 TRPV4

1.50e-0419613276053_UP
DrugKaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A

PGGHG KLF4 PAPSS2 RGS12 URB1 PITX1 LYL1

1.50e-0419613273579_UP
DrugEtidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A

ATN1 KLF4 RGS12 SRRT BAZ2A PITX1 MBD2

1.50e-0419613274564_UP
DrugLY294002; Down 200; 10uM; PC3; HT_HG-U133A

ATN1 ARHGEF40 MICALL2 SYNJ1 PITX1 COBL ZFP69B

1.50e-0419613275970_DN
DrugSB 202190; Up 200; 1uM; MCF7; HT_HG-U133A

ATN1 LZTS3 PAPSS2 RGS12 MGAT3 SYNJ1 PPP6R2

1.50e-0419613277054_UP
DrugMeticrane [1084-65-7]; Up 200; 14.6uM; HL60; HT_HG-U133A

JADE2 KDM5C PAPSS2 SYNJ1 PRRC2C RBM19 PLD2

1.50e-0419613271834_UP
DrugPalmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

ZCWPW1 PIDD1 DGKE KLF4 SYNJ1 BAZ2A PPP6R2

1.50e-0419613272795_DN
DrugIohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A

PIDD1 RGS12 URB1 MGAT3 SYNJ1 ZFHX2 BEGAIN

1.50e-0419613275704_UP
DrugMethiazole; Down 200; 15uM; MCF7; HT_HG-U133A

ATN1 LZTS3 JADE2 SIPA1L3 SMARCD3 PLD2 LYL1

1.50e-0419613273878_DN
DrugTetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A

RGS12 TGFB1I1 ABLIM1 BAZ2A PITX1 LYL1 MVP

1.50e-0419613272888_DN
DrugHydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A

ATN1 TRPM2 RGS12 URB1 MS4A1 SMARCD3 AHNAK2

1.55e-0419713272889_UP
DrugGinkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A

WHRN ATN1 URB1 MS4A1 SCN8A SMARCD3 MBD2

1.55e-0419713274121_UP
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; HL60; HT_HG-U133A

ZCWPW1 LZTS3 KDM5C RBM26 PIDD1 MICALL2 BAZ2A

1.55e-0419713272980_DN
DrugFolic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A

KDM5C PAPSS2 RGS12 SRRT SYNJ1 KMT2A SMARCD3

1.55e-0419713272783_DN
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A

PGGHG SIPA1L3 RGS12 URB1 SMARCD3 AHNAK2 BEGAIN

1.55e-0419713274764_UP
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A

ATN1 LZTS3 RGS12 SRRT SHANK2 CACNG4 LYL1

1.55e-0419713273412_UP
DrugSulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A

PGGHG SRRT MTA1 MGAT3 BAZ2A TRIM36 AHNAK2

1.55e-0419713271693_UP
Drugclozapine; Down 200; 10uM; MCF7; HT_HG-U133A

JADE2 KDM5C PIDD1 BAZ2A ZFHX2 SMARCD3 AHNAK2

1.55e-0419713275589_DN
DrugDroperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A

SIPA1L3 URB1 ARHGEF40 MTA1 SYNJ1 COBL MBD2

1.55e-0419713274629_UP
DrugFlorfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

KDM5C SIPA1L3 KLF4 DCUN1D4 SRRT CACNG4 PPP6R2

1.55e-0419713275300_DN
DrugCefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

WHRN URB1 MTA1 BAZ2A PLD2 TRIM36 PPP6R2

1.55e-0419713273247_UP
DrugGossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A

WHRN ATN1 LZTS3 SIPA1L3 SRRT SMARCD3 PPP6R2

1.59e-0419813274762_DN
Drugnordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A

ATN1 KDM5C TGFB1I1 MICALL2 BAZ2A PITX1 AHNAK2

1.59e-0419813271648_UP
DrugAndrosterone [53-41-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A

WHRN PIDD1 RGS12 ITPKB MGAT3 PITX1 BEGAIN

1.59e-0419813272650_UP
DrugLiothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A

WHRN PIDD1 RGS12 MGAT3 APOLD1 RBM19 TRIM36

1.59e-0419813274947_UP
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

ZCWPW1 KDM5C ITPKB TGFB1I1 PITX1 CACNG4 PPP6R2

1.59e-0419813274979_DN
DrugPrazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

WHRN RBM26 RGS12 PRX GSPT2 MBD2 BEGAIN

1.59e-0419813275416_UP
DrugTribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A

ATN1 PGGHG KLF4 URB1 ARHGEF40 SHANK2 NCAN

1.59e-0419813275429_UP
DrugBenzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A

ATN1 SIPA1L3 RGS12 TGFB1I1 APOLD1 RBM19 PLD2

1.59e-0419813274808_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SIPA1L3 DGKE BCL9 RBM19 CACNG4 PLD2 ZFP69B

1.59e-0419813275431_DN
DrugDelcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A

WHRN LZTS3 TRPM2 RGS12 SRRT PNMA8A SCN8A

1.59e-0419813276033_UP
DrugQuinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A

PIDD1 KLF4 BAZ2A RBM19 KMT2A COBL LYL1

1.59e-0419813273793_DN
DrugIobenguane sulfate; Up 200; 10.8uM; PC3; HT_HG-U133A

WHRN SIPA1L3 TRPM2 MTA1 PLEKHG6 PITX1 SCN8A

1.59e-0419813277299_UP
DrugMetampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A

ATN1 ITPKB SRRT ABLIM1 MICALL2 ADGRE5 TRIM36

1.59e-0419813272286_DN
DrugPirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A

ATN1 LZTS3 ITGA5 KLF4 RGS12 LARP4B PITX1

1.64e-0419913275497_DN
DrugAmidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A

ATN1 LZTS3 ITPKB SRRT GSPT2 MS4A1 MBD2

1.64e-0419913276818_UP
DrugPiretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A

LZTS3 MTA1 SHANK2 BAZ2A PNMA8A MBD2 BEGAIN

1.64e-0419913276828_UP
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A

SIPA1L3 DGKE RGS12 GSPT2 ADGRE5 TRIM36 MVP

1.64e-0419913276974_UP
DrugProgesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A

SIPA1L3 PAPSS2 RGS12 URB1 APOLD1 BAZ2A AHNAK2

1.64e-0419913273287_UP
DrugHemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A

PGGHG PIDD1 PRX ITPKB SRRT PITX1 TRIM36

1.64e-0419913273216_UP
DrugLevodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A

WHRN DGKE SRRT NCAN PITX1 CST3 SMARCD3

1.64e-0419913271472_UP
DrugNalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A

WHRN ZCWPW1 SIPA1L3 LARP4B MGAT3 CD74 CACNG4

1.64e-0419913277367_UP
DrugSulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A

ATN1 SIPA1L3 MTA1 MGAT3 PLEKHG6 BAZ2A LYL1

1.64e-0419913276212_UP
DrugSTOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A

ATN1 CAPZB RGS12 MTA1 SHANK2 MBD2 MVP

1.64e-0419913276906_UP
DrugThiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A

CPSF6 PIDD1 URB1 MTA1 APOLD1 ZFHX2 COBL

1.64e-0419913275756_DN
DrugOxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; PC3; HT_HG-U133A

WHRN KDM5C BCL9 MICALL2 PITX1 ZFP69B PPP6R2

1.64e-0419913276350_DN
DrugCefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A

SIPA1L3 RGS12 TGFB1I1 ABLIM1 SMARCD3 PLD2 MVP

1.64e-0419913276088_DN
DrugHippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A

ATN1 BCL9 SRRT BAZ2A SCN8A CACNG4 BEGAIN

1.70e-0420013273682_DN
DrugMyricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A

NECAB2 RGS12 URB1 PNMA8A SCN8A KMT2A MBD2

1.70e-0420013274170_UP
Diseaseearly-onset Parkinson's disease (implicated_via_orthology)

SYNJ1 PINK1

2.81e-0461292DOID:0060894 (implicated_via_orthology)
Diseasehepatocyte growth factor activator measurement

DOK7 RGS12

3.93e-0471292EFO_0008152
DiseaseLymphoid leukemia

KMT2A LYL1

5.22e-0481292C0023448
Diseasetriacylglycerol 56:8 measurement

DOK7 APOLD1 NCAN

5.24e-04361293EFO_0010435
DiseaseBipolar Disorder

WHRN TRPM2 BCL9 SRRT SHANK2 DAZAP1 NCAN SCN8A

1.22e-034771298C0005586
DiseaseGeneralized hypotonia

ATN1 POLR2A

1.92e-03151292C1858120
Diseaseapolipoprotein B measurement

PAQR9 PSD NPEPPS DOK7 SLC46A1 RGS12 NCAN EIF2B4 PPP6R2

2.60e-036631299EFO_0004615
DiseaseFeeding difficulties

ATN1 POLR2A

2.77e-03181292C0232466
DiseaseMeningioma

KLF4 CST3

3.09e-03191292C0025286
DiseaseManic Disorder

TRPM2 SHANK2 NCAN

3.76e-03711293C0024713

Protein segments in the cluster

PeptideGeneStartEntry
MPPRKKRRPASGDDL

DCUN1D4

61

Q92564
PDGPWGVGTPRMERK

ARHGEF40

1066

Q8TER5
GPPSFAVVGPDMKRR

ABLIM1

571

O14639
PMAVKGPNGRDPLLE

BCAR1

271

P56945
RAKPGTARLPGEDMR

BEGAIN

401

Q9BUH8
GLAPKRRAGDPGEMP

BAZ2A

1381

Q9UIF9
SMRSGRKKEAPGPRE

ATN1

11

P54259
AGRDPPAKDVMPGPR

ADGRE5

476

P48960
DSPGMVADRLPPKTG

ACTL9

36

Q8TC94
GPKPLFRRMSSLVGP

MS4A1

26

P11836
PPLEDGAMPSARLRK

CAPZB

81

P47756
DGRNIDPKPCTPRGM

DAZAP1

76

Q96EP5
SPGRPLEREKSPGRM

CIT

1971

O14578
MSGGRRKEEPPQPQL

RAB5IF

1

Q9BUV8
DGAPGAPVPMEEARR

RCOR2

391

Q8IZ40
GNFRDPDRMPGKTEP

RASAL3

176

Q86YV0
GMPAGKKRPPEARAE

RBM19

266

Q9Y4C8
GLTSGDMDLPPREKP

RBM26

461

Q5T8P6
MAPPAAPGRDRVGRE

HES6

1

Q96HZ4
GKGMERPAAREPHGP

APOLD1

31

Q96LR9
PVMPKKGPGSRREAS

PNMA8A

386

Q86V59
MNGKRPAEPGPARVG

OGFOD1

1

Q8N543
REGENPPDGFMAPKA

PAPSS2

586

O95340
MLRPDIFTGLRGPPK

FIGNL1

421

Q6PIW4
MEGSASPPEKPRARP

SLC46A1

1

Q96NT5
FKIPGSPPESMGRGR

GDI2

56

P50395
DGPPLRGSNMDFREP

EIF4H

186

Q15056
GSCMPEEPKPKRGRR

KLF4

406

O43474
SELGPPDPRLAMGSV

LZTS3

26

O60299
GTKMLERPPPGRPEE

MGAT3

121

Q09327
VEGKPRPMGSPRLGI

KIF26B

1056

Q2KJY2
DSEGGRAGSRAMKPP

JPT2

6

Q9H910
RPAGGRPSPSAMGKR

LARP4B

711

Q92615
ERKGPEMPRLFLDLG

LMTK3

1201

Q96Q04
RPSGRKPRPMGIIAA

DCLK3

336

Q9C098
DAGMGPPSAVAERPK

JADE2

726

Q9NQC1
FPADRMPPGAGLMER

MGAT5B

106

Q3V5L5
GRVGAGSRPKPEAPM

MICALL2

546

Q8IY33
GKRMGRGAPVEPSRE

GSPT2

101

Q8IYD1
ERAPGAPAFPLAIKM

PINK1

206

Q9BXM7
DQRPAGMLPNKTPRG

FAM205A

1081

Q6ZU69
LLHGGRKMPDSDAPP

FAM222B

226

Q8WU58
RPAGSEPRPEAGSMA

LRRC24

381

Q50LG9
DIAMRRDRGPKPALG

GARIN5A

61

Q6IPT2
PRGRGMLPIPVAAAK

MICU3

111

Q86XE3
RSAGRIQMSPPKLPG

PGGHG

681

Q32M88
GLAAMPEKRPFERLP

NPEPPSL1

41

A6NEC2
MKAELPPGPGAVGRE

EIF2B4

16

Q9UI10
PPGPGAVGREMTKEE

EIF2B4

21

Q9UI10
AKGPDGMALPRPRDQ

MVP

611

Q14764
MPRRLQPRGAGTKGP

PAQR9

1

Q6ZVX9
RTINRMPAKAPPGDE

CBLL1

46

Q75N03
RREAMRAEGAPASPP

OBSCN

226

Q5VST9
PMRLRDPEPEKRHGG

PLEKHG6

71

Q3KR16
GAPLLMDRTPDGRPQ

ITGA5

346

P08648
PGPRGPRATESGKRM

MBD2

136

Q9UBB5
KEGTRGPPPLPTDMR

MON1A

171

Q86VX9
GRAAKMAEAPASPAP

FOXO3B

81

A0A2Z4LIS9
SSLKMDPAGLEGGPR

ATP11AUN

31

Q6ZP68
MPLVGEGDRVKAPPD

CEFIP

961

Q711Q0
VELDKGVRAMPPPGL

IGSF22

886

Q8N9C0
GPPGREMDTARTPLS

CPSF6

396

Q16630
LTMDDGPPPRRARGD

CACNG4

46

Q9UBN1
LDKRRGRDPEMGGKP

CD247

86

P20963
VAERPLGEMGSPPAA

COL20A1

991

Q9P218
PAAAVGMIPGKDRGP

BCL9

1351

O00512
MDAPRASAAKPPTGR

COBL

1

O75128
PVPGMPRARKGNTLR

IFRD2

61

Q12894
DPDGSPGGAARPIKM

LYL1

256

P12980
AKSRGPTPPAMGPRD

MAP7D1

91

Q3KQU3
TAMGPSRRPPEPEKA

FMNL1

451

O95466
RNLMLPDGPKPQEDG

KMT2A

2596

Q03164
SSEPLEPEPGRARMG

EGLN2

21

Q96KS0
PMLGRRPGAPESKCS

CD74

31

P04233
GRLKMADRSSPQGRP

CCDC168

2651

Q8NDH2
MEAERRPAPGSPSEG

DGKE

1

P52429
AAGEAMVGASRPPPK

DOK7

306

Q18PE1
LSAFRREEPPRMPGG

FAM83H

351

Q6ZRV2
RMRKRDPGSAPSLGD

POLD1

906

P28340
APDRPSKPERAAMNG

PRRT3

331

Q5FWE3
GLAAMPEKRPFERLP

NPEPPS

41

P55786
KPPRLVGGPMDASVE

CST3

31

P01034
MDAVSRGPGREAPPL

PPP6R2

841

O75170
RMGLAPKDPALPGSS

PIDD1

886

Q9HB75
GKDMEPNGPSLPRDE

OSBPL5

46

Q9H0X9
GGMSLERLPEGLRPP

PITX1

6

P78337
RPLRKEMAGVGARGP

KATNAL1

121

Q9BW62
PSPSMDKIDRINRPG

TRIM36

86

Q9NQ86
SEGARPGSRMPLKSP

PSD

371

A5PKW4
PGVARREMEAPKSPG

SYNJ1

1151

O43426
GPLGRPRPDTVAMPK

TMEM183BP

6

Q1AE95
RMEKGIPASPRCGSP

ITPKB

256

P27987
MRGPGKDPTRKCPDP

NFAM1

191

Q8NET5
MEKGPVRAPAEKPRG

GCH1

1

P30793
APTDPMPRRRGRFKG

NCAN

471

O14594
PGSPEMERAGLQRKG

PIK3R6

356

Q5UE93
PRPMKVIDLPGGGAA

FN3K

71

Q9H479
GKVGISRRMPPPANL

PRRC2C

46

Q9Y520
VRPGLAPAGMEPARK

SMARCD3

56

Q6STE5
APAGMEPARKRAAPP

SMARCD3

61

Q6STE5
PRAPAMSAARKGRPG

SHC3

116

Q92529
MSAARKGRPGDEPLP

SHC3

121

Q92529
LAGGSRDPPRQPSDM

SIPA1L3

1391

O60292
ESMKARQPPGPGAGD

WHRN

501

Q9P202
KMPTRLDGERPGPNR

MTA1

431

Q13330
MEGQTPGSRGLPEKP

SLC38A8

1

A6NNN8
GRKRRPGEAEEMADP

URB1

2031

O60287
SPKAPFLGIPRGTMR

SHANK2

831

Q9UPX8
PEKLLGAERMPRAPG

SNAI3

136

Q3KNW1
PGKPRNRMVRGDPRA

SRRT

846

Q9BXP5
RKPRAQPTPGMSREG

AHNAK2

436

Q8IVF2
EGLSRKDLFEGRPPM

TCEAL1

71

Q15170
RGEDGDKAAPPPMSA

SF3B2

71

Q13435
DAQPLKARGPSAMPD

TTLL8

626

A6PVC2
GRKSTAPPAPRMGRK

ZCWPW1

516

Q9H0M4
APPAPRMGRKEGQGN

ZCWPW1

521

Q9H0M4
AAKGPRDELGPSFPM

TMEM74B

11

Q9NUR3
MAKRPGPPGSREMGL

ZNF735

1

P0CB33
AMTGGPDPRLKQADP

UBTFL1

311

P0CB47
ERPPMAKEGNEAGPS

ZFHX2

1411

Q9C0A1
MFRAGEASKRPLPGP

RGS12

1

O14924
GPLGRPRPDTVAMPK

TMEM183A

6

Q8IXX5
DRVGRPDRGLPLPME

RBMXL3

1016

Q8N7X1
ALPGGSREPGEMLPR

TRPM2

1386

O94759
MPKLGRAESPSRGKP

PRX

806

Q9BXM0
ELPGLPRAMQKSGRP

POLR2A

321

P24928
MAKRPGPPGSREMGL

ZNF716

1

A6NP11
MAARLLAPPGPDSFK

SCN8A

1

Q9UQD0
MAKRPGPPGSREMGL

ZNF479

1

Q96JC4
EEPRKMRSPPGENPS

ZNF496

16

Q96IT1
SEVMPGPIGLPRKRD

ZFP69B

236

Q9UJL9
PGLGPEEPRAAMGKA

STRCP1

1496

A6NGW2
SHMPRSGAPKERPAE

TGFB1I1

16

O43294
FKRGADPGMPEPTVL

TOMM7

36

Q9P0U1
GLTLFPDPRGPRAME

PVRIG

306

Q6DKI7
NREMPSLPRAGPEGS

PLD2

141

O14939
SMACPMGSGDPRKPR

ZMYND15

251

Q9H091
RPAGPGDGRPNLRMK

TRPV4

56

Q9HBA0
PASDPLREGSGKDMP

KDM5C

1331

P41229
MMKTEPRGPGGPLRS

PPP1R9B

1

Q96SB3
ARMGEPRESLAPAAP

NECAB2

36

Q7Z6G3